Education
About Us
Working with TipRanks
Follow Us
Fresh Tracks Therapeutics, Inc. (FRTX)
OTHER OTC:FRTX
FRTX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.03 - $1.03
Previous CloseN/A
Volume127.00
Average Volume (3M)N/A
Market Cap
$5.59M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.19
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.41
Shares Outstanding7,811,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.56
Price to Sales (P/S)0.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Fresh Tracks Therapeutics News
FRTX FAQ
What was Fresh Tracks Therapeutics, Inc.’s price range in the past 12 months?
Fresh Tracks Therapeutics, Inc. lowest stock price was $0.03 and its highest was $1.03 in the past 12 months.
What is Fresh Tracks Therapeutics, Inc.’s market cap?
Fresh Tracks Therapeutics, Inc.’s market cap is $5.59M.
When is Fresh Tracks Therapeutics, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Fresh Tracks Therapeutics, Inc.’s earnings last quarter?
Currently, no data Available
Is Fresh Tracks Therapeutics, Inc. overvalued?
According to Wall Street analysts Fresh Tracks Therapeutics, Inc.’s price is currently Overvalued.
Does Fresh Tracks Therapeutics, Inc. pay dividends?
Fresh Tracks Therapeutics, Inc. does not currently pay dividends.
What is Fresh Tracks Therapeutics, Inc.’s EPS estimate?
Fresh Tracks Therapeutics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fresh Tracks Therapeutics, Inc. have?
Fresh Tracks Therapeutics, Inc. has 7,811,000 shares outstanding.
What happened to Fresh Tracks Therapeutics, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Fresh Tracks Therapeutics, Inc.?
Currently, no hedge funds are holding shares in FRTX
Company Description
Fresh Tracks Therapeutics, Inc.
Fresh Tracks Therapeutics (FRTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies targeting dermatological diseases and conditions. Operating within the biotechnology and healthcare sectors, FRTX is dedicated to addressing unmet medical needs through its diverse pipeline of therapeutic candidates, leveraging cutting-edge research and development to deliver effective solutions to patients.
Fresh Tracks Therapeutics (FRTX) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
EyePoint Pharmaceuticals
―
Revance Therapeutics
―
NRX Pharmaceuticals
―
Arcutis Biotherapeutics
―
Ownership Overview
29.91% Insiders
<0.01% Other Institutional Investors
70.09% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---